Página 11 de resultados Sector: Atención sanitaria Área de negocio: Biotecnología Mercado de valores: precios y cotizaciones
Lista de todas las acciones y valores con precios, capitalizaciones de mercado, P/G y EPS
Todos los países
- {{country.name}}
- Todos los países
- Estados Unidos (1012)
- Australia (58)
- Austria (16)
- Bélgica (7)
- Brasil (16)
- Canadá (83)
- China (94)
- Dinamarca (6)
- Finlandia (4)
- Francia (41)
- Alemania (738)
- Hong Kong (46)
- India (19)
- Irlanda (1)
- Israel (19)
- Italia (4)
- Japón (37)
- México (28)
- Países Bajos (3)
- Nueva Zelanda (1)
- Noruega (14)
- Polonia (9)
- Rusia (2)
- Corea del Sur (12)
- España (4)
- Suecia (70)
- Suiza (11)
- Taiwán (67)
- Tailandia (2)
- Turquía (1)
- Reino Unido (69)
Todos los intercambios
- {{item.name}}
- Todos los intercambios
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- Nasdaq (1)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Atención sanitaria (2611)
- {{item.name}}
- Todos los sectores
- Atención sanitaria (2611)
Biotecnología (2611)
- {{item.name}}
- Todas las industrias
- Biotecnología (2611)
- Fabricante de Medicamentos-General (279)
- Fabricante de Medicamentos-Especializado y Genérico (1705)
- Planes de Salud (57)
- Centros de Atención Médica (553)
- Pharmaceutical Retailers (155)
- Servicios de Información Sanitaria (419)
- Dispositivos Médicos (913)
- Instrumentos y Suministros Médicos (501)
- Diagnósticos y Análisis (427)
- Distribución Médica (138)
| Nombre Nombre | Precio Precio |
24h% 7d chart 24h% 7d chart |
Cap.mercado Сap. del mercado | Vol. Volumen | bajo en 24h | alto en 24h | Сap. del mercado | PER | BPA |
|---|
| Nombre Nombre | Precio Precio |
24h% 7d chart 24h% 7d chart |
Cap.mercado Сap. del mercado | Vol. Volumen | bajo en 24h | alto en 24h | Сap. del mercado | PER | BPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $392.65 429.22 USD |
0
|
$100.83B 110.22B USD | $6 6.56 USD | $391.45 427.91 USD | $394.45 431.19 USD | $100.83B 110.22B USD | 0 | -$3.34 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $389.7 425.99 USD |
-1.38
|
$100.07B 109.39B USD | $2 2.19 USD | $389.7 425.99 USD | $389.7 425.99 USD | $100.07B 109.39B USD | 0 | -$3.4 -3.7 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $389.6 425.89 USD |
-0.69
|
$100.05B 109.37B USD | $0 0 USD | $389.6 425.89 USD | $391.4 427.85 USD | $100.05B 109.37B USD | 0 | -$3.33 -3.6 USD | |
| CSL CMXHF | $158.4 — |
0
|
$76.7B — | $54 — | $151.5 — | $151.5 — | $76.7B — | 29.06 | $5.45 — | |
| CSL Limited CSJ.F | $137.2 149.98 USD |
+0.09
|
$66.81B 73.03B USD | $50 54.66 USD | $137.2 149.98 USD | $137.2 149.98 USD | $66.81B 73.03B USD | 28.70 | $4.78 5.23 USD | |
| CSL Limited CSJA.F | $68 74.33 USD |
0
|
$66.75B 72.96B USD | $5 5.47 USD | $68 74.33 USD | $68 74.33 USD | $66.75B 72.96B USD | 28.21 | $2.41 2.63 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $9,823.71 581.68 USD |
+3.54
|
$1.07T 63.22B USD | $1.15K 68.33 USD | $9,781.23 579.17 USD | $9,827 581.88 USD | $1.07T 63.22B USD | 12.59 | $780 46.19 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $47.3 9.59 USD |
+2.8
|
$311.03B 63.04B USD | $0 0 USD | $0 0 USD | $0 0 USD | $311.03B 63.04B USD | 12.54 | $3.77 0.76 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,040,000 785.03 USD |
+0.68
|
$74.02T 55.87B USD | $72.43K 54.67 USD | $1,023,000 772.2 USD | $1,041,000 785.78 USD | $74.02T 55.87B USD | 0 | $0 0 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $455.1 497.49 USD |
+3.62
|
$50.77B 55.5B USD | $0 0 USD | $455.1 497.49 USD | $455.1 497.49 USD | $50.77B 55.5B USD | 13.18 | $34.52 37.74 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $84.94 17.22 USD |
-1.53
|
$221.5B 44.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $221.5B 44.9B USD | 0 | -$0.58 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $131.95 26.74 USD |
0
|
$201.42B 40.82B USD | $0 0 USD | $0 0 USD | $0 0 USD | $201.42B 40.82B USD | 35.95 | $3.67 0.74 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $263.4 287.93 USD |
+1.11
|
$35.14B 38.41B USD | $30 32.79 USD | $263.4 287.93 USD | $263.4 287.93 USD | $35.14B 38.41B USD | 0 | -$1.8 -1.9 USD | |
| Bonus BioGroup BBIXF | $0.05 — |
+50899
|
$36.05B — | $20.03K — | $0.0002999 — | $0.0002999 — | $36.05B — | 0 | -$0.01 — | |
| argenx SE ARGX.VI | $517.4 565.59 USD |
+0.51
|
$31.68B 34.63B USD | $0 0 USD | $517.4 565.59 USD | $517.4 565.59 USD | $31.68B 34.63B USD | 36.03 | $14.36 15.7 USD | |
| argenx SE ARGNF | $562 — |
0
|
$34.59B — | $10 — | $562 — | $562 — | $34.59B — | 34.22 | $16.42 — | |
| UCB SA UCB.VI | $162 177.09 USD |
+0.59
|
$31.11B 34.01B USD | $0 0 USD | $162 177.09 USD | $163.75 179 USD | $31.11B 34.01B USD | 29.56 | $5.48 5.99 USD | |
| argenx SE 1AE.F | $506.4 553.56 USD |
-1.9
|
$30.92B 33.8B USD | $10 10.93 USD | $506.4 553.56 USD | $506.4 553.56 USD | $30.92B 33.8B USD | 34.78 | $14.56 15.92 USD | |
| argenx SE 1AEA.F | $505 552.03 USD |
-1.94
|
$30.91B 33.79B USD | $100 109.31 USD | $505 552.03 USD | $505 552.03 USD | $30.91B 33.79B USD | 34.28 | $14.73 16.1 USD | |
| UCB SA UNC0.F | $79 86.36 USD |
-1.25
|
$30.54B 33.39B USD | $50 54.66 USD | $79 86.36 USD | $79 86.36 USD | $30.54B 33.39B USD | 28.83 | $2.74 3 USD | |
| UCB SA UNC.F | $160.05 174.96 USD |
-1.48
|
$30.47B 33.31B USD | $1 1.09 USD | $160.05 174.96 USD | $160.05 174.96 USD | $30.47B 33.31B USD | 29.25 | $5.47 5.98 USD | |
| UCB SA UCBJF | $174.55 — |
-2.7
|
$33.17B — | $100 — | $174.55 — | $174.55 — | $33.17B — | 27.88 | $6.26 — | |
| BeOne Medicines Ltd. 49BA.F | $228 249.23 USD |
+3.64
|
$27.96B 30.56B USD | $15 16.4 USD | $228 249.23 USD | $228 249.23 USD | $27.96B 30.56B USD | 0 | -$3.12 -3.4 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BioNTech SE B1NT34.SA | $38.07 7.72 USD |
-0.57
|
$146.43B 29.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $146.43B 29.68B USD | 0 | -$1.27 -0.2 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
+0.58
|
$25.73B 28.13B USD | $509 556.41 USD | $16.6 18.15 USD | $16.6 18.15 USD | $25.73B 28.13B USD | 0 | -$0.24 -0.2 USD | |
| Celltrion, Inc. 068270.KS | $162,200 122.43 USD |
+1.25
|
$36.72T 27.72B USD | $352.7K 266.23 USD | $158,100 119.34 USD | $162,200 122.43 USD | $36.72T 27.72B USD | 0 | $0 0 USD | |
| BioNTech SE BNTX.VI | $95.7 104.61 USD |
+0.68
|
$23.12B 25.28B USD | $39 42.63 USD | $95.6 104.5 USD | $95.9 104.83 USD | $23.12B 25.28B USD | 0 | -$3.19 -3.4 USD | |
| BioNTech SE 22UA.F | $96.1 105.05 USD |
-0.16
|
$23.1B 25.25B USD | $496 542.2 USD | $95.1 103.96 USD | $96.35 105.32 USD | $23.1B 25.25B USD | 0 | -$3.16 -3.4 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.MU | $29.31 32.04 USD |
0
|
$16.46B 17.99B USD | $0 0 USD | $29.31 32.04 USD | $29.31 32.04 USD | $16.46B 17.99B USD | 13.69 | $2.14 2.34 USD | |
| Royalty Pharma plc RPD.F | $28.92 31.61 USD |
-1.13
|
$16.27B 17.79B USD | $15 16.4 USD | $28.92 31.61 USD | $28.92 31.61 USD | $16.27B 17.79B USD | 13.57 | $2.13 2.33 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.83B 16.81B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.83B 16.81B USD | 28.48 | $51.95 3.08 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Innovent Biologics, Inc. 6IB.F | $8.9 9.73 USD |
+2.3
|
$14.79B 16.17B USD | $500 546.57 USD | $8.9 9.73 USD | $8.95 9.78 USD | $14.79B 16.17B USD | 0 | -$0.01 -0.01 USD | |
| Innovent Biologics IVBXF | $9.5 — |
+28.55
|
$15.56B — | $400 — | $9.5 — | $9.5 — | $15.56B — | 0 | -$0.01 — | |
| Incyte Corporation INCY.MX | $1,180.69 69.91 USD |
0
|
$258.47B 15.3B USD | $0 0 USD | $0 0 USD | $0 0 USD | $258.47B 15.3B USD | 312.35 | $3.78 0.22 USD | |
| Incyte Corporation I1NC34.SA | $192.28 38.97 USD |
0
|
$75.3B 15.26B USD | $0 0 USD | $0 0 USD | $0 0 USD | $75.3B 15.26B USD | 343.35 | $0.56 0.11 USD | |
| United Therapeutics Corporation UTH.F | $285.9 312.53 USD |
+1.13
|
$13.13B 14.36B USD | $15 16.4 USD | $285.9 312.53 USD | $285.9 312.53 USD | $13.13B 14.36B USD | 12.84 | $22.25 24.32 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.8 6.34 USD |
+2.65
|
$12.13B 13.26B USD | $208 227.37 USD | $5.8 6.34 USD | $5.8 6.34 USD | $12.13B 13.26B USD | 29.00 | $0.2 0.22 USD | |
| Genmab A/S GMAB.VI | $196.65 214.97 USD |
+1.65
|
$12.13B 13.26B USD | $0 0 USD | $196.65 214.97 USD | $198.15 216.6 USD | $12.13B 13.26B USD | 13.15 | $14.95 16.34 USD | |
| Incyte Corporation ICY.F | $60.96 66.64 USD |
+1.7
|
$12.06B 13.19B USD | $22 24.05 USD | $60.96 66.64 USD | $60.96 66.64 USD | $12.06B 13.19B USD | 338.66 | $0.18 0.2 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.93 3.2 USD |
+1.51
|
$12B 13.11B USD | $500 546.57 USD | $2.93 3.2 USD | $2.93 3.2 USD | $12B 13.11B USD | 29.27 | $0.1 0.11 USD | |
| WuXi Biologics (Cayman) WXIBF | $3.2 — |
0
|
$13.02B — | $400 — | $3.2 — | $3.2 — | $13.02B — | 29.09 | $0.11 — | |
| Genmab A/S GNMSF | $207.75 — |
-4.76
|
$12.97B — | $84 — | $207.5 — | $207.85 — | $12.97B — | 12.19 | $17.04 — | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Moderna, Inc. MRNA.MX | $549 32.51 USD |
+5.19
|
$212.32B 12.57B USD | $40 2.37 USD | $549 32.51 USD | $549 32.51 USD | $212.32B 12.57B USD | 0 | -$175.9 -10.4 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Insmed Incorporated IM8N.SG | $61.5 67.23 USD |
0
|
$11.29B 12.34B USD | $0 0 USD | $61.5 67.23 USD | $61.5 67.23 USD | $11.29B 12.34B USD | 0 | -$5.06 -5.5 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $158.1 32.04 USD |
0
|
$60.71B 12.31B USD | $0 0 USD | $0 0 USD | $0 0 USD | $60.71B 12.31B USD | 20.96 | $7.54 1.53 USD | |
| Insmed Incorporated IM8N.F | $61.5 67.23 USD |
-3.91
|
$11.2B 12.24B USD | $130 142.11 USD | $61.5 67.23 USD | $61.5 67.23 USD | $11.2B 12.24B USD | 0 | -$5.26 -5.7 USD | |
| Ascendis Pharma A/S A1SN34.SA | $65.49 13.27 USD |
0
|
$58.3B 11.82B USD | $0 0 USD | $0 0 USD | $0 0 USD | $58.3B 11.82B USD | 0 | -$37.17 -7.5 USD | |
| Sino Biopharmaceutical SBHMY | $9.75 — |
+2.85
|
$11.12B — | $44 — | $9.75 — | $9.75 — | $11.12B — | 33.62 | $0.29 — | |
| Exelixis, Inc. EX9.F | $37.26 40.73 USD |
-1.06
|
$10.16B 11.11B USD | $225 245.96 USD | $37.26 40.73 USD | $37.26 40.73 USD | $10.16B 11.11B USD | 19.01 | $1.96 2.14 USD | |
| Verona Pharma plc I9SA.F | $71.2 77.83 USD |
-1.66
|
$9.72B 10.63B USD | $14 15.3 USD | $71.2 77.83 USD | $72.4 79.14 USD | $9.72B 10.63B USD | 0 | -$1.7 -1.8 USD | |
| Moderna, Inc. 0QF.MU | $24.42 26.69 USD |
+1.52
|
$9.69B 10.59B USD | $0 0 USD | $24.42 26.69 USD | $24.42 26.69 USD | $9.69B 10.59B USD | 0 | -$7.72 -8.4 USD | |
| Akeso, Inc. 4RY.F | $10.6 11.59 USD |
+10.42
|
$9.66B 10.56B USD | $172 188.02 USD | $10.6 11.59 USD | $10.7 11.7 USD | $9.66B 10.56B USD | 0 | -$0.08 -0.08 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $49.78 54.42 USD |
+0.12
|
$9.57B 10.47B USD | $0 0 USD | $49.78 54.42 USD | $49.97 54.62 USD | $9.57B 10.47B USD | 21.00 | $2.37 2.59 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $49.61 54.23 USD |
+0.02
|
$9.57B 10.46B USD | $115 125.71 USD | $49.61 54.23 USD | $49.61 54.23 USD | $9.57B 10.46B USD | 20.41 | $2.43 2.66 USD | |
| Moderna, Inc. MRNA.VI | $24.56 26.85 USD |
-1.39
|
$9.5B 10.38B USD | $75 81.99 USD | $24.49 26.77 USD | $24.62 26.91 USD | $9.5B 10.38B USD | 0 | -$7.66 -8.3 USD | |
| Moderna, Inc. 0QF.F | $24.46 26.74 USD |
-1.45
|
$9.46B 10.34B USD | $329 359.64 USD | $24.22 26.48 USD | $24.86 27.17 USD | $9.46B 10.34B USD | 0 | -$7.88 -8.6 USD | |
| Ascendis Pharma A/S A71.F | $151 165.06 USD |
+0.67
|
$9.24B 10.11B USD | $60 65.59 USD | $151 165.06 USD | $151 165.06 USD | $9.24B 10.11B USD | 0 | -$5.65 -6.1 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.39 1.9 USD |
0
|
$44.16B 8.95B USD | $0 0 USD | $0 0 USD | $0 0 USD | $44.16B 8.95B USD | 62.60 | $0.15 0.03 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.45 — |
-18.81
|
$8.78B — | $2.5K — | $0.45 — | $0.45 — | $8.78B — | 44.89 | $0.01 — | |
| Bio-Techne Corporation TECH.MX | $931.52 55.16 USD |
-36.59
|
$148.01B 8.76B USD | $0 0 USD | $0 0 USD | $0 0 USD | $148.01B 8.76B USD | 36.67 | $25.4 1.5 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Blueprint Medicines Corporation 2L9.F | $111.15 121.5 USD |
-0.36
|
$7.23B 7.9B USD | $30 32.79 USD | $111.15 121.5 USD | $111.15 121.5 USD | $7.23B 7.9B USD | 0 | -$2.19 -2.3 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $1,018.51 60.31 USD |
0
|
$128.02B 7.58B USD | $0 0 USD | $0 0 USD | $0 0 USD | $128.02B 7.58B USD | 14.14 | $72.01 4.26 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Bio-Techne Corporation TE1.F | $43 47 USD |
-1.83
|
$6.74B 7.37B USD | $50 54.66 USD | $43 47 USD | $43 47 USD | $6.74B 7.37B USD | 57.33 | $0.75 0.82 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $33.88 37.04 USD |
+1.35
|
$6.58B 7.2B USD | $100 109.31 USD | $33.88 37.04 USD | $33.88 37.04 USD | $6.58B 7.2B USD | 0 | -$3.12 -3.4 USD | |
| Roivant Sciences Ltd. 87S.F | $9.56 10.45 USD |
-0.62
|
$6.56B 7.17B USD | $600 655.88 USD | $9.56 10.45 USD | $9.59 10.48 USD | $6.56B 7.17B USD | 0 | -$0.65 -0.7 USD | |
| Revolution Medicines, Inc. 42Z.F | $35 38.26 USD |
-1.13
|
$6.55B 7.16B USD | $86 94.01 USD | $35 38.26 USD | $35 38.26 USD | $6.55B 7.16B USD | 0 | -$3.56 -3.8 USD | |
| Corcept Therapeutics Incorporated HTD.F | $60.84 66.51 USD |
-0.26
|
$6.54B 7.15B USD | $11 12.02 USD | $60.84 66.51 USD | $61.12 66.81 USD | $6.54B 7.15B USD | 60.23 | $1.01 1.1 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.9 20.66 USD |
0
|
$6.52B 7.12B USD | $7 7.65 USD | $18.9 20.66 USD | $18.9 20.66 USD | $6.52B 7.12B USD | 0 | -$4.48 -4.8 USD | |
| 3SBio Inc. 83B.F | $2.66 2.91 USD |
+9.92
|
$6.32B 6.91B USD | $150 163.97 USD | $2.66 2.91 USD | $2.68 2.93 USD | $6.32B 6.91B USD | 24.18 | $0.11 0.12 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$111.78B 6.62B USD | $0 0 USD | $0 0 USD | $0 0 USD | $111.78B 6.62B USD | 0 | -$57.25 -3.3 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $47.54 51.97 USD |
+0.42
|
$5.9B 6.45B USD | $9 9.84 USD | $47.54 51.97 USD | $47.54 51.97 USD | $5.9B 6.45B USD | 14.31 | $3.32 3.63 USD | |
| Financière de Tubize SA FTD.SG | $129.2 141.23 USD |
+1.25
|
$5.87B 6.41B USD | $0 0 USD | $127 138.83 USD | $129.2 141.23 USD | $5.87B 6.41B USD | 63.96 | $2.02 2.21 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $96.7 105.71 USD |
-1.61
|
$5.85B 6.4B USD | $20 21.86 USD | $96.7 105.71 USD | $96.7 105.71 USD | $5.85B 6.4B USD | 14.92 | $6.48 7.08 USD | |
| Financière de Tubize SA FTD.F | $126.8 138.61 USD |
-3.21
|
$5.64B 6.17B USD | $70 76.52 USD | $126.8 138.61 USD | $126.8 138.61 USD | $5.64B 6.17B USD | 61.25 | $2.07 2.26 USD | |
| Legend Biotech Corporation 9LB.F | $30.2 33.01 USD |
-0.66
|
$5.57B 6.09B USD | $230 251.42 USD | $30.2 33.01 USD | $30.2 33.01 USD | $5.57B 6.09B USD | 0 | -$1.02 -1.1 USD | |
| TG Therapeutics, Inc. NKB2.F | $34.51 37.72 USD |
-0.43
|
$5.52B 6.04B USD | $45 49.19 USD | $34.51 37.72 USD | $34.51 37.72 USD | $5.52B 6.04B USD | 156.84 | $0.22 0.24 USD | |
| ALK-Abelló A/S 4AJ0.F | $25.1 27.44 USD |
+0.16
|
$5.52B 6.03B USD | $15 16.4 USD | $25.1 27.44 USD | $25.1 27.44 USD | $5.52B 6.03B USD | 44.03 | $0.57 0.62 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $242.8 265.41 USD |
-0.82
|
$5.41B 5.91B USD | $50 54.66 USD | $242.8 265.41 USD | $242.8 265.41 USD | $5.41B 5.91B USD | 0 | -$15.64 -17.09 USD | |
| Telix Pharmaceuticals TLPPF | $17.59 — |
+2.51
|
$5.91B — | $15 — | $17.59 — | $17.59 — | $5.91B — | 195.44 | $0.09 — | |
| Ionis Pharmaceuticals, Inc. ISI.F | $32 34.98 USD |
+4.4
|
$5.36B 5.85B USD | $755 825.32 USD | $32 34.98 USD | $32 34.98 USD | $5.36B 5.85B USD | 0 | -$2.61 -2.8 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $92,900 70.12 USD |
+0.22
|
$7.28T 5.49B USD | $135.24K 102.08 USD | $91,500 69.07 USD | $93,100 70.28 USD | $7.28T 5.49B USD | 0 | $0 0 USD | |
| ALK-Abelló A/S 0OIR.IL | $186.3 27.32 USD |
+24.66
|
$37.4B 5.48B USD | $257 37.68 USD | $186 27.27 USD | $187 27.42 USD | $37.4B 5.48B USD | 115.71 | $1.61 0.24 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
|
Sin acciones favoritas
Aún no tiene una acción favorita, agréguela a favoritos para verla aquí |
||||||||||